Convergence Science Agenda
We’re bringing together intellectual, investment and technology communities and expertise to accelerate development of a universal influenza vaccine.
A New Paradigm for an Age-Old Problem: The Threat of Influenza
The ‘Convergence Research’ paradigm combines previously distinct knowledge and methods from across the science and technology landscape to shape novel pathways and innovative approaches for overcoming long-standing and vexing societal challenges. Using this framework, next-generation influenza vaccines are Sabin’s target. Building on recommendations of the Sabin-Aspen Vaccine Science & Policy Group, our work will convene a diverse and bold set of thinkers and leaders to stimulate the expanded intellectual and capital investment required to transform vaccine protection against the threat of influenza.
Emerging Convergence Scholarship
Advancing emerging opportunities for next-generation influenza vaccines will require the engagement of the next-generation of scientific and technology leaders. Sabin is supporting three innovative graduate-level students to contribute to developing our Convergence Science Agenda as Emerging Convergence Scholars. Awardees will attend one of three meetings to be held in Boston, Singapore, and Spain, respectively. There, emerging scholars will have the opportunity to engage with transdisciplinary experts as they collaborate to build a Convergence Science Agenda and to share these ideas and their experience through multimedia channels, inclusive of Sabin’s Influenzer community.